Equillium Stock Current Valuation
| EQ Stock | USD 1.79 0.07 4.07% |
Valuation analysis of Equillium helps investors to measure Equillium's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of 04/25/2024, Enterprise Value Over EBITDA is likely to drop to -0.2. In addition to that, Enterprise Value Multiple is likely to drop to -0.2. Fundamental drivers impacting Equillium's valuation include:
Price Book 2.9518 | Enterprise Value 20.6 M | Enterprise Value Ebitda (2.19) | Price Sales 1.8075 | Forward PE 3.4364 |
Undervalued
Today
Please note that Equillium's price fluctuation is dangerous at this time. Calculation of the real value of Equillium is based on 3 months time horizon. Increasing Equillium's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Equillium is useful when determining the fair value of the Equillium stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Equillium. Since Equillium is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Equillium Stock. However, Equillium's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.79 | Real 3.37 | Target 8.0 | Hype 1.97 | Naive 1.6 |
The real value of Equillium Stock, also known as its intrinsic value, is the underlying worth of Equillium Company, which is reflected in its stock price. It is based on Equillium's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Equillium's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Equillium's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Equillium helps investors to forecast how Equillium stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Equillium more accurately as focusing exclusively on Equillium's fundamentals will not take into account other important factors: Equillium Company Current Valuation Analysis
Equillium's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Equillium Current Valuation | 20.6 M |
Most of Equillium's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Equillium is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Equillium Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Equillium is extremely important. It helps to project a fair market value of Equillium Stock properly, considering its historical fundamentals such as Current Valuation. Since Equillium's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Equillium's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Equillium's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Equillium has a Current Valuation of 20.6 M. This is 99.86% lower than that of the Biotechnology sector and 99.56% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.88% higher than that of the company.
Equillium Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Equillium's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Equillium could also be used in its relative valuation, which is a method of valuing Equillium by comparing valuation metrics of similar companies.Equillium is currently under evaluation in current valuation category among related companies.
Equillium Current Valuation Drivers
We derive many important indicators used in calculating different scores of Equillium from analyzing Equillium's financial statements. These drivers represent accounts that assess Equillium's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Equillium's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 58.7M | 108.9M | 108.6M | 35.8M | 25.1M | 23.9M | |
| Enterprise Value | 55.2M | 93.2M | 68.2M | (13.2M) | 2.7M | 2.6M |
Equillium Fundamentals
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.37) % | ||||
| Operating Margin | (0.35) % | ||||
| Current Valuation | 20.6 M | ||||
| Shares Outstanding | 35.25 M | ||||
| Shares Owned By Insiders | 36.42 % | ||||
| Shares Owned By Institutions | 21.76 % | ||||
| Number Of Shares Shorted | 394.47 K | ||||
| Price To Earning | (6.70) X | ||||
| Price To Book | 2.95 X | ||||
| Price To Sales | 1.81 X | ||||
| Revenue | 36.08 M | ||||
| Gross Profit | 15.76 M | ||||
| EBITDA | (14.4 M) | ||||
| Net Income | (13.34 M) | ||||
| Cash And Equivalents | 57.56 M | ||||
| Cash Per Share | 1.68 X | ||||
| Total Debt | 824 K | ||||
| Debt To Equity | 0.29 % | ||||
| Current Ratio | 3.98 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (21.78 M) | ||||
| Short Ratio | 1.53 X | ||||
| Earnings Per Share | (0.38) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 44 | ||||
| Beta | 1.67 | ||||
| Market Capitalization | 60.64 M | ||||
| Total Asset | 50.53 M | ||||
| Retained Earnings | (185.74 M) | ||||
| Working Capital | 21.78 M | ||||
| Current Asset | 60.04 M | ||||
| Current Liabilities | 1.81 M | ||||
| Net Asset | 50.53 M |
About Equillium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Equillium in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Equillium's short interest history, or implied volatility extrapolated from Equillium options trading.
Pair Trading with Equillium
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.Moving together with Equillium Stock
| 0.65 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
Moving against Equillium Stock
| 0.46 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Equillium Piotroski F Score and Equillium Altman Z Score analysis. To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Equillium Stock analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.38) | Revenue Per Share 1.039 | Quarterly Revenue Growth (0.42) | Return On Assets (0.14) | Return On Equity (0.49) |
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.